Oncopeptides AB (publ) (ONPPF) Research

Oncopeptides AB (publ) is a biotechnology company focused on developing pharmaceutical therapies to combat cancer. The firm's therapeutic innovations are intended for markets across the United States, Europe, and internationally. Its flagship product candidate, melflufen, is an advanced anti-cancer peptide drug conjugate specifically designed to treat adult patients afflicted with relapsed refractory multiple myeloma. Oncopeptides AB (publ) was founded in 2000 and is headquartered in Stockholm, Sweden.

Market snapshot

Symbol
ONPPF
Price
$0.27
Day change
0.00%
Market cap
$369.5M
P/E ratio
-1.97x
52-week range
0.265-0.265
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Alpha Cognition Inc. (ACOGF)
  • Biostage, Inc. (BSTG)
  • Small Pharma Inc. (DMTTF)
  • Herantis Pharma Oyj (HRPMF)
  • Karolinska Development AB (publ) (KDEVF)
  • MCI Onehealth Technologies Inc. (MCIOF)
  • Mindset Pharma Inc. (MSSTF)
  • Medivir AB (publ) (MVRBF)

Open Oncopeptides AB (publ) (ONPPF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.